94 related articles for article (PubMed ID: 9707523)
1. Reasons for non-compliance in colorectal cancer screening with fecal occult blood test.
Li T; Nakama H; Wei N
Eur J Med Res; 1998 Aug; 3(8):397-400. PubMed ID: 9707523
[TBL] [Abstract][Full Text] [Related]
2. Screen compliance rates in 14-years annual screening program for colorectal cancer with immunochemical fecal occult blood test-- identification of higher priority subjects in health education.
Wei N; Nakama H; Li T
Eur J Med Res; 1998 Jul; 3(7):341-4. PubMed ID: 9682030
[TBL] [Abstract][Full Text] [Related]
3. Nonmedical costs of colorectal cancer screening with the fecal occult blood test and colonoscopy.
Heitman SJ; Au F; Manns BJ; McGregor SE; Hilsden RJ
Clin Gastroenterol Hepatol; 2008 Aug; 6(8):912-917.e1. PubMed ID: 18534918
[TBL] [Abstract][Full Text] [Related]
4. Survey of the opinions, knowledge, and practices of gastroenterologists regarding colorectal cancer screening and use of the fecal occult blood test.
Sharma VK; Corder FA; Fancher J; Howden CW
Am J Gastroenterol; 2000 Dec; 95(12):3629-32. PubMed ID: 11151904
[TBL] [Abstract][Full Text] [Related]
5. Screening for colorectal cancer by faecal occult blood test: why people choose to refuse.
Worthley DL; Cole SR; Esterman A; Mehaffey S; Roosa NM; Smith A; Turnbull D; Young GP
Intern Med J; 2006 Sep; 36(9):607-10. PubMed ID: 16911554
[TBL] [Abstract][Full Text] [Related]
6. Survey of internal medicine residents' use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance.
Sharma VK; Corder FA; Raufman JP; Sharma P; Fennerty MB; Howden CW
Am J Gastroenterol; 2000 Aug; 95(8):2068-73. PubMed ID: 10950059
[TBL] [Abstract][Full Text] [Related]
7. Many participants in fecal occult blood test population screening have a higher-than-average risk for colorectal cancer.
Worthley DL; Smith A; Bampton PA; Cole SR; Young GP
Eur J Gastroenterol Hepatol; 2006 Oct; 18(10):1079-83. PubMed ID: 16957514
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan.
Lee KJ; Inoue M; Otani T; Iwasaki M; Sasazuki S; Tsugane S;
Cancer Detect Prev; 2007; 31(1):3-11. PubMed ID: 17289293
[TBL] [Abstract][Full Text] [Related]
9. Faecal occult blood test-based screening programme with high compliance for colonoscopy has a strong clinical impact on colorectal cancer.
Parente F; Marino B; DeVecchi N; Moretti R; ; Ucci G; Tricomi P; Armellino A; Redaelli L; Bargiggia S; Cristofori E; Masala E; Tortorella F; Gattinoni A; Odinolfi F; Pirola ME
Br J Surg; 2009 May; 96(5):533-40. PubMed ID: 19358181
[TBL] [Abstract][Full Text] [Related]
10. [Acceptance of screening colonoscopy in the prevention of colorectal cancer in relation to some demographic factors].
Homa K; Brzosko M; Safranow K; Marlicz K
Pol Merkur Lekarski; 2005 Aug; 19(110):179-82. PubMed ID: 16245428
[TBL] [Abstract][Full Text] [Related]
11. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme.
Malila N; Oivanen T; Hakama M
Z Gastroenterol; 2008 Apr; 46 Suppl 1():S25-8. PubMed ID: 18368636
[TBL] [Abstract][Full Text] [Related]
12. Characteristics and survival rate of elderly patients with colorectal cancer detected by immunochemical occult blood screening.
Zhang B; Fattah A; Nakama H
Hepatogastroenterology; 2000; 47(32):414-8. PubMed ID: 10791202
[TBL] [Abstract][Full Text] [Related]
13. Understanding non-compliance to colorectal cancer screening: a case control study, nested in a randomised trial [ISRCTN83029072].
Giorgi Rossi P; Federici A; Bartolozzi F; Farchi S; Borgia P; Guasticchi G
BMC Public Health; 2005 Dec; 5():139. PubMed ID: 16372903
[TBL] [Abstract][Full Text] [Related]
14. [Feasibility of colorectal cancer screening with fecal occult blood test distributed by public pharmacies].
Pippa G; Ferrara M; Valle S; Diego B; Alessandra B; Apuzzo M; Bazuro ME; Tammaro G; Federici A
Recenti Prog Med; 2009; 100(7-8):348-51. PubMed ID: 19725474
[TBL] [Abstract][Full Text] [Related]
15. Breast and colorectal cancer screening among low-income women with psychiatric disorders.
Friedman LC; Puryear LJ; Moore A; Green CE
Psychooncology; 2005 Sep; 14(9):786-91. PubMed ID: 15690427
[TBL] [Abstract][Full Text] [Related]
16. Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood test.
van Rijn AF; van Rossum LG; Deutekom M; Laheij RJ; Fockens P; Bossuyt PM; Dekker E; Jansen JB
J Public Health (Oxf); 2008 Dec; 30(4):461-5. PubMed ID: 18716047
[TBL] [Abstract][Full Text] [Related]
17. Limitations of the faecal occult blood test in screening for colorectal cancer.
Delcò F; Sonnenberg A
Ital J Gastroenterol Hepatol; 1999 Mar; 31(2):119-26. PubMed ID: 10363196
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
19. Overcoming barriers to colorectal cancer screening tests.
Lachter J; Leska-Aharoni T; Warum D; Eliakim R
Isr Med Assoc J; 2008; 10(8-9):621-6. PubMed ID: 18847166
[TBL] [Abstract][Full Text] [Related]
20. Do benefits and barriers differ by stage of adoption for colorectal cancer screening?
Rawl SM; Menon U; Champion VL; May FE; Loehrer P; Hunter C; Azzouz F; Monahan PO; Skinner CS
Health Educ Res; 2005 Apr; 20(2):137-48. PubMed ID: 15314036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
